24 related articles for article (PubMed ID: 35012851)
1. Patterns of
Xiao Q; Zhang W; Jing J; Zhong T; Li D; Zhou J; Liu P; Duan Z; Gao H; Shen L
Front Endocrinol (Lausanne); 2023; 14():1184895. PubMed ID: 38027167
[TBL] [Abstract][Full Text] [Related]
2. Metastatic cyclin D1 positive lobular breast carcinoma as a potential lymphoma mimicker.
Ghani HA; Kavuri SB; Garcia JD; Zahner CJ; Lyapichev KA
EJHaem; 2023 Nov; 4(4):1174-1175. PubMed ID: 38024639
[No Abstract] [Full Text] [Related]
3. Correction: Surgery of the primary tumor in patients with de novo metastatic breast cancer: a nationwide population-based retrospective cohort study in Belgium.
Brandão M; Martins-Branco D; De Angelis C; Vuylsteke P; Gelber RD; Van Damme N; van Walle L; Ferreira AR; Lambertini M; Poggio F; Verhoeven D; Barbeaux A; Duhoux FP; Wildiers H; Caballero C; Awada A; Piccart-Gebhart M; Punie K; de Azambuja E
Breast Cancer Res Treat; 2024 Apr; ():. PubMed ID: 38592543
[No Abstract] [Full Text] [Related]
4. HR
Torrisi R; Jacobs F; Miggiano C; De Sanctis R; Santoro A
Drugs Context; 2023; 12():. PubMed ID: 36926051
[TBL] [Abstract][Full Text] [Related]
5. The prognosis of invasive ductal carcinoma, lobular carcinoma and mixed ductal and lobular carcinoma according to molecular subtypes of the breast.
Zhao H
Breast Cancer; 2021 Jan; 28(1):187-195. PubMed ID: 32812198
[TBL] [Abstract][Full Text] [Related]
6. Subdivision of M1 Stage for De Novo Metastatic Breast Cancer to Better Predict Prognosis and Response to Primary Tumor Surgery.
Lin C; Wu J; Ding S; Goh C; Andriani L; Lu S; Shen K; Zhu L
J Natl Compr Canc Netw; 2019 Dec; 17(12):1521-1528. PubMed ID: 31805535
[TBL] [Abstract][Full Text] [Related]
7. Adjuvant chemotherapy could not bring survival benefit to HR-positive, HER2-negative, pT1b-c/N0-1/M0 invasive lobular carcinoma of the breast: a propensity score matching study based on SEER database.
Hu G; Hu G; Zhang C; Lin X; Shan M; Yu Y; Lu Y; Niu R; Ye H; Wang C; Xu C
BMC Cancer; 2020 Feb; 20(1):136. PubMed ID: 32085753
[TBL] [Abstract][Full Text] [Related]
8. Prognostic factors and survival according to tumour subtype in women presenting with breast cancer bone metastases at initial diagnosis: a SEER-based study.
Li X; Zhang X; Liu J; Shen Y
BMC Cancer; 2020 Nov; 20(1):1102. PubMed ID: 33187507
[TBL] [Abstract][Full Text] [Related]
9. Comparison between de novo and metachronous metastatic breast cancer: the presence of a primary tumour is not the only difference-a Dutch population-based study from 2008 to 2018.
de Maar JS; Luyendijk M; Suelmann BBM; van der Kruijssen DEW; Elias SG; Siesling S; van der Wall E
Breast Cancer Res Treat; 2023 Apr; 198(2):253-264. PubMed ID: 36648694
[TBL] [Abstract][Full Text] [Related]
10. De novo metastatic lobular breast carcinoma: A population-based study from SEER database.
Sun MS; Yan HC; Gao M; Liu HJ; Xu L
Asian J Surg; 2022 Dec; 45(12):2608-2617. PubMed ID: 35012851
[TBL] [Abstract][Full Text] [Related]
11. [A comparative study of metastatic patterns of ductal and lobular carcinoma of the breast from two matched series (376 patients)].
Fondrinier E; Guérin O; Lorimier G
Bull Cancer; 1997 Dec; 84(12):1101-7. PubMed ID: 9587361
[TBL] [Abstract][Full Text] [Related]
12. Invasive Pleomorphic Lobular Carcinoma of the Breast: Pathologic, Clinical, and Therapeutic Considerations.
Al-Baimani K; Bazzarelli A; Clemons M; Robertson SJ; Addison C; Arnaout A
Clin Breast Cancer; 2015 Dec; 15(6):421-5. PubMed ID: 26209026
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
